pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Ruediger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; von Weikerstahl, Ludwig Fischer; Clemens, Michael R.; Gauler, Thomas C.; Maerten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas; Boeck, Stefan

pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

Autor(en):

Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Ruediger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; von Weikerstahl, Ludwig Fischer; Clemens, Michael R.; Gauler, Thomas C.; Maerten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas; Boeck, Stefan

Tübinger Autor(en):

Sipos, Bence

Erschienen in:

Bmc Cancer (2014), Bd. 14, Article 624

Verlagsangabe:

Biomed Central Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1186/1471-2407-14-624

ISSN:

1471-2407